Publikationen in Zusammenarbeit mit Forschern von University of Pavia (20)

2022

  1. Hybrid Lipid/Clay Carrier Systems Containing Annatto Oil for Topical Formulations

    Pharmaceutics, Vol. 14, Núm. 5, pp. 1067

2020

  1. Correlation between elemental composition/mobility and skin cell proliferation of fibrous nanoclay/spring water hydrogels

    Pharmaceutics, Vol. 12, Núm. 9, pp. 1-20

  2. Wound healing activity of nanoclay/spring water hydrogels

    Pharmaceutics, Vol. 12, Núm. 5

2019

  1. Halloysite nanotubes as tools to improve the actual challenge of fixed doses combinations in tuberculosis treatment

    Journal of Biomedical Materials Research - Part A, Vol. 107, Núm. 7, pp. 1513-1521

  2. Montmorillonite-norfloxacin nanocomposite intended for healing of infected wounds

    International Journal of Nanomedicine, Vol. 14, pp. 5051-5060

2016

  1. Health and Medical Applications of Tubular Clay Minerals

    Developments in Clay Science (Elsevier B.V.), pp. 708-725

2014

  1. A novel bioadhesive semisolid formulation containing chitosan and tetracycline/layered clay complexes for local delivery into periodontal pockets

    Materials Technology, Vol. 29, Núm. B2, pp. B108-B113

  2. Intercalation of tetracycline into layered clay mineral material for drug delivery purposes

    Materials Technology, Vol. 29, Núm. B2, pp. B96-B99

  3. Intestinal permeability of oxytetracycline from chitosan-montmorillonite nanocomposites

    Colloids and Surfaces B: Biointerfaces, Vol. 117, pp. 441-448

  4. Montmorillonite-chitosan-silver sulfadiazine nanocomposites for topical treatment of chronic skin lesions: In vitro biocompatibility, antibacterial efficacy and gap closure cell motility properties

    Carbohydrate Polymers, Vol. 102, Núm. 1, pp. 970-977

  5. Solid state characterisation of silver sulfadiazine loaded on montmorillonite/chitosan nanocomposite for wound healing

    Colloids and Surfaces B: Biointerfaces, Vol. 113, pp. 152-157

2013

  1. Networking and rheology of concentrated clay suspensions "matured" in mineral medicinal water

    International Journal of Pharmaceutics, Vol. 453, Núm. 2, pp. 473-479

2012

  1. In vitro biocompatibility and mucoadhesion of montmorillonite chitosan nanocomposite: A new drug delivery

    Applied Clay Science, Vol. 55, pp. 131-137

2011

  1. Assessement of anti-inflammatory properties of microspheres prepared with chitosan and 5-amino salicylic acid over inflamed Caco-2 cells

    Carbohydrate Polymers, Vol. 85, Núm. 3, pp. 638-644

2010

  1. Chitosan-silicate biocomposites to be used in modified drug release of 5-aminosalicylic acid (5-ASA)

    Applied Clay Science, Vol. 50, Núm. 1, pp. 106-111

  2. Suitability of natural sulphur-rich muds from Copahue (Argentina) for use as semisolid health care products

    Applied Clay Science, Vol. 49, Núm. 3, pp. 205-212

2007

  1. Use of clays as drug delivery systems: Possibilities and limitations

    Applied Clay Science, Vol. 36, Núm. 1-3, pp. 22-36

  2. Uses of clay minerals in semisolid health care and therapeutic products

    Applied Clay Science, Vol. 36, Núm. 1-3, pp. 37-50

2005

  1. Influence of dispersion conditions of two pharmaceutical grade clays on their interaction with some tetracyclines

    Applied Clay Science, Vol. 30, Núm. 2, pp. 79-86

2001

  1. Use of water uptake and capillary suction time measures for evaluation of the anti-diarrhoeic properties of fibrous clays

    Applied Clay Science, Vol. 20, Núm. 1-2, pp. 81-86